Clinical Trial Update: A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Zovaglutide in overweight and obesity; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Zovaglutide

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Overweight , Obesity | Phase 3 | Status: NOT_YET_RECRUITING